Jefferies sees Monash IVF's Fertility North acquisition profitable, raises PT

Monash IVF

19/12/2023 19:36

** Jefferies says Monash IVF Group's  MVF.AX  Fertility
North acquisition will increase its Western Australia market
share by about 1,400 basis points
    ** Brokerage hikes PT to A$1.50 from A$1.45, maintains
"hold" rating
    ** Brokerage assumes the acquisition will lead to 3% price
growth in FY25 for the MVF Australian franchise
    ** "We worry about potentially lower levels of discretionary
spend in Australia leading to lower volumes of IVF in the
medium-term, which will be partly offset by this acquisition" -
brokerage 
    ** 5 of 6 analysts rate the stock "buy" and 1 "hold"; median
PT A$1.48 – LSEG
    ** Stock up 41.4% YTD, as of last close

 ($1 = 1.4791 Australian dollars)

 (Reporting by Rajasik Mukherjee in Bengaluru)
 ((Rajasik.Mukherjee@thomsonreuters.com))